Zobrazeno 1 - 10
of 37
pro vyhledávání: '"LM Muul"'
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 132(3)
Interpretation of results with the use of effector populations generated in human mixed lymphocyte tumor cultures (MLTC) has in many cases been clouded by the presence of two distinct cytolytic effectors: specific cytolytic T lymphocytes (CTL) and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a52e84f7f97b93d08cedd3cd6e98a67
https://pubmed.ncbi.nlm.nih.gov/6198383
https://pubmed.ncbi.nlm.nih.gov/6198383
Autor:
Muul LM; GMBB, National Human Genome Institute, Bethesda, Maryland, USA., Heine G, Silvin C, James SP, Candotti F, Radbruch A, Worm M
Publikováno v:
Current protocols in immunology [Curr Protoc Immunol] 2011 Aug; Vol. Chapter 7, pp. Unit7.10.
Autor:
Davis BR; Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, USA. brian.r.davis@uth.tmc.edu, Yan Q, Bui JH, Felix K, Moratto D, Muul LM, Prokopishyn NL, Blaese RM, Candotti F
Publikováno v:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2010 Apr; Vol. 135 (1), pp. 72-83. Date of Electronic Publication: 2010 Feb 02.
Autor:
Watford WT; Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA. watfordw@mail.nih.gov, Hissong BD, Durant LR, Yamane H, Muul LM, Kanno Y, Tato CM, Ramos HL, Berger AE, Mielke L, Pesu M, Solomon B, Frucht DM, Paul WE, Sher A, Jankovic D, Tsichlis PN, O'Shea JJ
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2008 Nov 24; Vol. 205 (12), pp. 2803-12. Date of Electronic Publication: 2008 Nov 10.
Autor:
Muul LM; GMBB, National Human Genome Institute, Bethesda, Maryland, USA., Silvin C, James SP, Candotti F
Publikováno v:
Current protocols in immunology [Curr Protoc Immunol] 2008 Aug; Vol. Chapter 7, pp. Unit 7.10.1-7.10.24.
Autor:
Davis BR; Institute for Inherited Disease Research, Newtown, PA, USA. Brian.R.Davis@uth.tmc.edu, Dicola MJ, Prokopishyn NL, Rosenberg JB, Moratto D, Muul LM, Candotti F, Michael Blaese R
Publikováno v:
Blood [Blood] 2008 May 15; Vol. 111 (10), pp. 5064-7. Date of Electronic Publication: 2008 Mar 10.
Autor:
Muul LM; Genetics and Molecular Biology Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892-1451, USA. muu11@mail.nih.gov, Candotti F
Publikováno v:
Current gene therapy [Curr Gene Ther] 2007 Oct; Vol. 7 (5), pp. 361-8.
Autor:
Sakamoto N; Division of Therapeutic Proteins, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20892, USA., Tsuji K, Muul LM, Lawler AM, Petricoin EF, Candotti F, Metcalf JA, Tavel JA, Lane HC, Urba WJ, Fox BA, Varki A, Lunney JK, Rosenberg AS
Publikováno v:
Blood [Blood] 2007 Jul 15; Vol. 110 (2), pp. 501-8. Date of Electronic Publication: 2007 Mar 29.
Autor:
Muul LM; Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. muul1@mail.nih.gov, Tuschong LM, Soenen SL, Jagadeesh GJ, Ramsey WJ, Long Z, Carter CS, Garabedian EK, Alleyne M, Brown M, Bernstein W, Schurman SH, Fleisher TA, Leitman SF, Dunbar CE, Blaese RM, Candotti F
Publikováno v:
Blood [Blood] 2003 Apr 01; Vol. 101 (7), pp. 2563-9. Date of Electronic Publication: 2002 Nov 27.
Autor:
Tuschong L; Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-1820, USA., Soenen SL, Blaese RM, Candotti F, Muul LM
Publikováno v:
Human gene therapy [Hum Gene Ther] 2002 Sep 01; Vol. 13 (13), pp. 1605-10.